Cardiol Therapeutics (CRDL) Inventory (2020 - 2022)

Cardiol Therapeutics' Inventory history runs 3 years deep, the most recent figure standing at $259966.1 for Q3 2022.

• Quarterly Inventory fell 3.48% year-over-year to $259966.1 in Q3 2022, while the trailing twelve-month figure through Sep 2022 was $259966.1 (down 3.48% YoY) and the FY2021 annual result came in at $270547.6, up 1917.09% from the prior year.
• Inventory was $259966.1 for Q3 2022 at Cardiol Therapeutics, down from $265931.5 in the prior quarter.
• Across five years, Inventory topped out at $275827.2 in Q2 2021 and bottomed at $13782.4 in Q4 2020.
• A 3-year average of $231643.8 and a median of $267672.4 in 2022 frame the typical range for Inventory.
• Annual changes were most pronounced in 2021 — Inventory surged 1851.62% — and 2022, when it fell 3.59%.
• Cardiol Therapeutics' Inventory stood at $13782.4 in 2020, then jumped by 1851.62% to $268981.4 in 2021, then slipped by 3.35% to $259966.1 in 2022.
• Business Quant data shows CRDL's Inventory at $259966.1 in Q3 2022, $265931.5 in Q2 2022, and $267672.4 in Q1 2022.